NO20001542D0 - Novel benzo (3,4) cyclobuta (1,2) pyrrole compounds, processes for their preparation and pharmaceutical compositions containing them - Google Patents
Novel benzo (3,4) cyclobuta (1,2) pyrrole compounds, processes for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- NO20001542D0 NO20001542D0 NO20001542A NO20001542A NO20001542D0 NO 20001542 D0 NO20001542 D0 NO 20001542D0 NO 20001542 A NO20001542 A NO 20001542A NO 20001542 A NO20001542 A NO 20001542A NO 20001542 D0 NO20001542 D0 NO 20001542D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- cyclobuta
- alkenyl
- Prior art date
Links
- -1 benzo (3,4) cyclobuta (1,2) pyrrole compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 15
- 125000003118 aryl group Chemical group 0.000 abstract 13
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 10
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 150000003233 pyrroles Chemical class 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 abstract 2
- 125000004385 trihaloalkyl group Chemical group 0.000 abstract 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 abstract 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
- 125000004952 trihaloalkoxy group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
cis-Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives (I) are new. cis-Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives of formula (I) and their isomers and salts are new. R1 - R3 = H, halogen, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, OH, 1-6C alkoxy, cycloalkyl, cycloalkyl(1-6C)alkyl, aryl, aryl(1-6C)alkyl, aryloxy, aryl(1-6C)alkoxy, 1-6C trihaloalkyl, 1-6C trihaloalkoxy,CN, NO2, OSO2Me, OSO2CF3, NR6R7 or COOR6; or two adjacent R1 - R3 groups = 4-8C optionally saturated ring in which 1-2 C atoms can be replaced by O, N and/or S; R6, R7 = H, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, cycloalkyl, cycloalkyl(1-6C)alkyl, aryl or aryl(1-6C)alkyl; R4 = H, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, cycloalkyl, cycloalkyl(1-6C)alkyl, aryl, aryl(1-6C)alkyl, heterocycloalkyl, heterocycloalkyl(1-6C)alkyl, heteroaryl or heteroaryl(1-6C)alkyl; R5 = aryl or heteroaryl optionally substituted by halogen, OH, 1-6C alkyl, 1-6C alkoxy, 2-6C alkenyl, cycloalkyl, adamantyl, cycloalkyl(1-6C)alkyl, aryl, aryl(1-6C)alkyl, aryloxy, aryl(1-6C)alkoxy, 1-6C trihaloalkyl, CN, NO2, oxo, OSO2Me, OSO2CF3, NR6R7 or COOR6; n = 1 - 3; cycloalkyl = a 3-8C mono- or bicyclic optionally saturated ring system optionally substituted by halogen and/or 1-6C alkyl; heterocycloalkyl = cycloalkyl as defined in which the ring system contains 1-3 heteroatoms selected from O, N and S; aryl = phenyl, naphthyl, dihydronaphthyl, tetrahydronaphthyl, indenyl or indanyl; heteroaryl = aryl as defined containing 1-3 heteroatoms selected from O, N and S. An Independent claim is also included for a process for preparing (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9903811A FR2791345B1 (en) | 1999-03-26 | 1999-03-26 | NOVEL BENZO [3,4] CYCLOBUTA [1,2-C] PYRROLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20001542D0 true NO20001542D0 (en) | 2000-03-24 |
| NO20001542L NO20001542L (en) | 2000-09-27 |
| NO315513B1 NO315513B1 (en) | 2003-09-15 |
Family
ID=9543685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001542A NO315513B1 (en) | 1999-03-26 | 2000-03-24 | New Benzo [3,4] Cyclobuta [1,2] Pyrrole Compounds, Methods of Their Preparation and Pharmaceutical Compositions Containing Them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6153640A (en) |
| EP (1) | EP1038873B1 (en) |
| JP (1) | JP3256788B2 (en) |
| KR (1) | KR100427127B1 (en) |
| CN (1) | CN1166638C (en) |
| AT (1) | ATE216994T1 (en) |
| AU (1) | AU762990B2 (en) |
| BR (1) | BR0001420A (en) |
| CA (1) | CA2301787C (en) |
| DE (1) | DE60000142T2 (en) |
| DK (1) | DK1038873T3 (en) |
| EA (1) | EA003302B1 (en) |
| ES (1) | ES2176156T3 (en) |
| FR (1) | FR2791345B1 (en) |
| HK (1) | HK1031380A1 (en) |
| HU (1) | HUP0001246A3 (en) |
| NO (1) | NO315513B1 (en) |
| NZ (1) | NZ503588A (en) |
| PL (1) | PL339203A1 (en) |
| PT (1) | PT1038873E (en) |
| SI (1) | SI1038873T1 (en) |
| ZA (1) | ZA200001501B (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4171369A (en) * | 1972-09-29 | 1979-10-16 | Sandoz Ltd. | Hydro-4-phenyl-benz[f]isoindoline compounds |
| FI57748C (en) * | 1972-09-29 | 1980-10-10 | Sandoz Ag | ANALOGIFICATION OF THE ANTIDPRESSIVE BENS (F) ISOINDOLINER FRAMSTAELLNING AV NYA ANTIDEPRESSIVA BENS (F) |
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| DE3576334D1 (en) * | 1984-07-25 | 1990-04-12 | Abbott Lab | 1,2,3,3A, 8,8A-HEXAHYDRO-INDENO- (1,2-C) PYRRDE. |
| US4622405A (en) * | 1984-07-25 | 1986-11-11 | Abbott Laboratories | 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
| GB9012469D0 (en) * | 1990-06-05 | 1990-07-25 | Glaxo Group Ltd | Medicaments |
| US5574060A (en) * | 1993-08-12 | 1996-11-12 | The United States Of America As Represented By The Department Of Health And Human Services | Selective inhibitors of biogenic amine transporters |
| DE4341402A1 (en) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituted azabicycloheptane derivatives, their preparation and use |
-
1999
- 1999-03-26 FR FR9903811A patent/FR2791345B1/en not_active Expired - Fee Related
-
2000
- 2000-03-23 US US09/533,684 patent/US6153640A/en not_active Expired - Fee Related
- 2000-03-24 EP EP00400812A patent/EP1038873B1/en not_active Expired - Lifetime
- 2000-03-24 ES ES00400812T patent/ES2176156T3/en not_active Expired - Lifetime
- 2000-03-24 EA EA200000260A patent/EA003302B1/en not_active IP Right Cessation
- 2000-03-24 BR BR0001420-6A patent/BR0001420A/en not_active Application Discontinuation
- 2000-03-24 JP JP2000083880A patent/JP3256788B2/en not_active Expired - Fee Related
- 2000-03-24 ZA ZA200001501A patent/ZA200001501B/en unknown
- 2000-03-24 CA CA002301787A patent/CA2301787C/en not_active Expired - Fee Related
- 2000-03-24 CN CNB001083325A patent/CN1166638C/en not_active Expired - Fee Related
- 2000-03-24 AT AT00400812T patent/ATE216994T1/en not_active IP Right Cessation
- 2000-03-24 AU AU22579/00A patent/AU762990B2/en not_active Ceased
- 2000-03-24 NZ NZ503588A patent/NZ503588A/en unknown
- 2000-03-24 DK DK00400812T patent/DK1038873T3/en active
- 2000-03-24 DE DE60000142T patent/DE60000142T2/en not_active Expired - Fee Related
- 2000-03-24 HU HU0001246A patent/HUP0001246A3/en unknown
- 2000-03-24 PL PL00339203A patent/PL339203A1/en not_active Application Discontinuation
- 2000-03-24 NO NO20001542A patent/NO315513B1/en unknown
- 2000-03-24 KR KR10-2000-0015002A patent/KR100427127B1/en not_active IP Right Cessation
- 2000-03-24 PT PT00400812T patent/PT1038873E/en unknown
- 2000-03-24 SI SI200030008T patent/SI1038873T1/en unknown
-
2001
- 2001-03-26 HK HK01102172A patent/HK1031380A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5631431A2 (en) | NEW SUBSTITUTED INDOLES | |
| NO961457L (en) | New pyridine compounds, processes in their preparation, and pharmaceutical compositions containing them | |
| AR037907A1 (en) | DERIVATIVES OF AZAINDOLILALQUILAMINA AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS | |
| ES2062458T3 (en) | DERIVATIVES FROM 1,2-BENZISOXAZOLE, ITS PREPARATION PROCEDURES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| NO20004295D0 (en) | New Pyridine Compounds, Methods of their Preparation, and Pharmaceutical Compositions Containing Them | |
| CO5031246A1 (en) | CALCILITICAL COMPOUNDS | |
| AR042002A1 (en) | SUBSTITUTED BENZOXAZINONAS, OBTAINING PROCESS AND USES FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. | |
| BR9812239A (en) | Compound, pharmaceutical formulation, use of the compound, processes for the treatment of disorders, for the treatment of disorders mediated by 5-hydroxytryptamine, and for the preparation of the compound | |
| NO974455L (en) | New falvon compounds, process of their preparation and pharmaceutical compositions containing them | |
| NO20005922D0 (en) | Novel dihydrofuro [3,4-6] quinolin-1-one compounds, process for their preparation and pharmaceutical compositions containing them | |
| NO20001542L (en) | Novel benzo (3,4) cyclobuta (1,2) pyrrole compounds, processes for their preparation and pharmaceutical compositions containing them | |
| CO4600635A1 (en) | PROCEDURES AND INTERMEDIATES TO PREPARE SUBSTITUTED CHROMANOL DERIVATIVES | |
| AR037591A1 (en) | PROCEDURES FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH AND USEFUL COMPOUNDS IN SUCH PROCEDURES | |
| MX9306394A (en) | DERIVATIVES OF BENZOFURANO, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM | |
| SE9002727D0 (en) | NOVEL CYCLIC KETONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS WELL AS A PROCESS FOR THEIR PREPARATION | |
| AR045549A1 (en) | 9-AMINO-PODOFILOTOXINA COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. | |
| NO20005103D0 (en) | Novel cyanoindole serotonin reuptake inhibitor compounds, process for their preparation and pharmaceutical compositions containing them | |
| NO20005797D0 (en) | Novel Aminopyrroline Compounds, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
| NO903512L (en) | NEW 1-OXA-2-OXO-8-AZASPIRO (4,5) DECANDER DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCEDURE FOR PREPARING THEM. | |
| NO964672L (en) | New Tetracyclic 1,4-Oxazine Compounds, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
| CO4761056A1 (en) | PROCEDURE FOR PREPARING CONDENSED CYCLOPENTAN DERIVATIVES WITH AROMATIC RINGS | |
| ES443519A1 (en) | Benzoisoindoline derivatives | |
| AR041653A1 (en) | BENZO COMPOUNDS (E) (1,4) OXAZINO (3,2-G) SUBSTITUTED ISOINDOL, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |